ClinicalTrials.govpublic full text
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
atopic dermatitis, pediatric atopic dermatitis, eczema, tapinarof, topical, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 870451
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.